UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 48

Sortiert nach

Recent Progress of Benzimidazole Hybrids for Anticancer Potential

Current medicinal chemistry, 2020-01, Vol.27 (35), p.5970

2020

Volltextzugriff (PDF)

Design, synthesis and in vitro biological activities of coumarin linked 1,3,4-oxadiazole hybrids as potential multi-target directed anti-Alzheimer agents

Journal of King Saud University. Science, 2022-06, Vol.34 (4), p.101977, Article 101977

2022

Volltextzugriff (PDF)

The emerging role of proteolysis targeting chimeras (PROTACs) in the treatment of Alzheimer’s disease

Medicinal chemistry research, 2023-04, Vol.32 (4), p.601-616

2023

Volltextzugriff (PDF)

Overview of Chemistry and Therapeutic Potential of Non-Nitrogen Heterocyclics as Anticonvulsant Agents

Current neuropharmacology, 2022, Vol.20 (8), p.1519-1553

2022

Volltextzugriff (PDF)

COVID19 inhibitors: A prospective therapeutics

Bioorganic chemistry, 2020-08, Vol.101, p.104027-104027, Article 104027

Jawaid Akhtar, Md

2020

Volltextzugriff (PDF)

Design, Synthesis, and Pharmacological Screening of Pyridazinone Hybrids as Anticonvulsant Agents

Archiv der Pharmazie (Weinheim), 2017-10, Vol.350 (10), p.n/a

2017

Volltextzugriff (PDF)

Voltage gated sodium channel inhibitors as anticonvulsant drugs: A systematic review on recent developments and structure activity relationship studies

Bioorganic chemistry, 2021-10, Vol.115, p.105230-105230, Article 105230

2021

Volltextzugriff (PDF)

Structural modification and strategies for the enhanced doxorubicin drug delivery

Bioorganic chemistry, 2022-03, Vol.120, p.105599-105599, Article 105599

2022

Volltextzugriff (PDF)

Synthesis of stable benzimidazole derivatives bearing pyrazole as anticancer and EGFR receptor inhibitors

Bioorganic chemistry, 2018-08, Vol.78, p.158-169

2018

Volltextzugriff (PDF)

Design, synthesis, docking and QSAR study of substituted benzimidazole linked oxadiazole as cytotoxic agents, EGFR and erbB2 receptor inhibitors

European journal of medicinal chemistry, 2017-01, Vol.126, p.853-869

2017

Volltextzugriff (PDF)

Design, synthesis and evaluation of piperazine clubbed 1,2,4-triazine derivatives as potent anticonvulsant agents

Journal of molecular structure, 2022-06, Vol.1257, p.132587, Article 132587

2022

Volltextzugriff (PDF)

Paradigms and Success Stories of Natural Products in Drug Discovery Against Neurodegenerative Disorders (NDDs)

Current neuropharmacology, 2024-01, Vol.22 (6), p.992-1015

2024

Volltextzugriff (PDF)

Rational drug design strategies for the development of promising multi-target directed indole hybrids as Anti-Alzheimer agents

Bioorganic chemistry, 2022-10, Vol.127, p.105941-105941, Article 105941

2022

Volltextzugriff (PDF)

Pyridazinone hybrids: Design, synthesis and evaluation as potential anticonvulsant agents

Bioorganic chemistry, 2018-04, Vol.77, p.74-83

2018

Volltextzugriff (PDF)

Current updates on the epidemiology, pathogenesis and development of small molecule therapeutics for the treatment of Ebola virus infections

Asian Pacific journal of tropical medicine, 2024-07, Vol.17 (7), p.285-298

2024

Volltextzugriff (PDF)

Anticancer Potential of the S‐Heterocyclic Ring Containing Drugs and its Bioactivation to Reactive Metabolites

Chemistry & biodiversity, 2024-07, Vol.21 (7), p.e202400473-n/a

2024

Volltextzugriff (PDF)

Design, Synthesis, and Biological Evaluation of 6-(2-Amino-substituted phenyl)-4-(substituted phenyl)-1,2,4-triazine-3,5(2H,4H)-dione Derivatives as Anticonvulsant Agents

Archiv der Pharmazie (Weinheim), 2016-04, Vol.349 (4), p.277-292

2016

Volltextzugriff (PDF)

Design, synthesis, and pharmacological evaluation of aryl oxadiazole linked 1,2,4-triazine derivatives as anticonvulsant agents

Medicinal chemistry research, 2022-05, Vol.31 (5), p.781-793

2022

Volltextzugriff (PDF)

Synthesis, in silico and in vitro studies of novel quinazolinone derivatives as potential SARS-CoV-2 3CLpro inhibitors

Arabian journal of chemistry, 2024-01, Vol.17 (1), p.105384, Article 105384

2024

Volltextzugriff (PDF)

Formulation and evaluation of nano lipid formulation containing CNS acting drug: molecular docking, in-vitro assessment and bioactivity detail in rats

Artificial cells, nanomedicine, and biotechnology, 2018-01, Vol.46 (sup2), p.46-57

2018

Volltextzugriff (PDF)

Correction to: Substituted phenyl containing 1,3,4-oxadiazole-2-yl-but-2-enamides: synthesis and preliminary evaluation as promising anticonvulsants

Medicinal chemistry research, 2019-06, Vol.28 (6), p.926-926

2019

Volltextzugriff (PDF)

Substituted phenyl containing 1,3,4-oxadiazole-2-yl-but-2-enamides: synthesis and preliminary evaluation as promising anticonvulsants

Medicinal chemistry research, 2014-11, Vol.23 (11), p.4915-4925

2014

Volltextzugriff (PDF)

Isatin containing heterocycles for different biological activities: Analysis of structure activity relationship

Journal of molecular structure, 2020-12, Vol.1222, p.128900, Article 128900

2020

Volltextzugriff (PDF)

Synthetic and therapeutic perspectives of nitrogen containing heterocycles as anti-convulsants

Bioorganic & medicinal chemistry, 2020-08, Vol.28 (15), p.115585-115585, Article 115585

2020

Volltextzugriff (PDF)

The growing concern of chlorpyrifos exposures on human and environmental health

Pesticide biochemistry and physiology, 2022-07, Vol.185, p.105138-105138, Article 105138

2022

Volltextzugriff (PDF)

1 – 25 von 48

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(45)
Mit Volltextzugriff
(47)

Publikationsform

Artikel
(48)

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Recent Progress of Benzimidazole Hybrids for Anticancer Potential

Design, synthesis and in vitro biological activities of coumarin linked 1,3,4-oxadiazole hybrids as potential multi-target directed anti-Alzheimer agents

The emerging role of proteolysis targeting chimeras (PROTACs) in the treatment of Alzheimer’s disease

Overview of Chemistry and Therapeutic Potential of Non-Nitrogen Heterocyclics as Anticonvulsant Agents

COVID19 inhibitors: A prospective therapeutics

Design, Synthesis, and Pharmacological Screening of Pyridazinone Hybrids as Anticonvulsant Agents

Voltage gated sodium channel inhibitors as anticonvulsant drugs: A systematic review on recent developments and structure activity relationship studies

Structural modification and strategies for the enhanced doxorubicin drug delivery

Synthesis of stable benzimidazole derivatives bearing pyrazole as anticancer and EGFR receptor inhibitors

Design, synthesis, docking and QSAR study of substituted benzimidazole linked oxadiazole as cytotoxic agents, EGFR and erbB2 receptor inhibitors

Design, synthesis and evaluation of piperazine clubbed 1,2,4-triazine derivatives as potent anticonvulsant agents

Paradigms and Success Stories of Natural Products in Drug Discovery Against Neurodegenerative Disorders (NDDs)

Rational drug design strategies for the development of promising multi-target directed indole hybrids as Anti-Alzheimer agents

Pyridazinone hybrids: Design, synthesis and evaluation as potential anticonvulsant agents

Current updates on the epidemiology, pathogenesis and development of small molecule therapeutics for the treatment of Ebola virus infections

Anticancer Potential of the S‐Heterocyclic Ring Containing Drugs and its Bioactivation to Reactive Metabolites

Design, Synthesis, and Biological Evaluation of 6-(2-Amino-substituted phenyl)-4-(substituted phenyl)-1,2,4-triazine-3,5(2H,4H)-dione Derivatives as Anticonvulsant Agents

Design, synthesis, and pharmacological evaluation of aryl oxadiazole linked 1,2,4-triazine derivatives as anticonvulsant agents

Synthesis, in silico and in vitro studies of novel quinazolinone derivatives as potential SARS-CoV-2 3CLpro inhibitors

Formulation and evaluation of nano lipid formulation containing CNS acting drug: molecular docking, in-vitro assessment and bioactivity detail in rats

Correction to: Substituted phenyl containing 1,3,4-oxadiazole-2-yl-but-2-enamides: synthesis and preliminary evaluation as promising anticonvulsants

Substituted phenyl containing 1,3,4-oxadiazole-2-yl-but-2-enamides: synthesis and preliminary evaluation as promising anticonvulsants

Isatin containing heterocycles for different biological activities: Analysis of structure activity relationship

Synthetic and therapeutic perspectives of nitrogen containing heterocycles as anti-convulsants

The growing concern of chlorpyrifos exposures on human and environmental health

Suchergebnisse filtern